Samrat Pharmachem Ltd Reports Q3 and Nine Months Ended December 31, 2025 Financial Results

Samrat Pharmachem Ltd has reported its financial results for the quarter and nine months ended December 31, 2025. The total income for the quarter is INR 7,891.84 lakhs, while the total expenses stand at INR 7,966.68 lakhs, leading to a loss before tax of INR 74.84 lakhs. The company reported a loss for the year of INR 58.73 lakhs and a basic and diluted earnings per equity share of INR 1.90. The company's net worth as on December 31, 2025, is INR 2,585.19 lakhs.